Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Atheric Pharmaceutical - aVenture Company Research

Atheric Pharmaceutical

Atheric Pharmaceutical

Atheric™ Pharmaceutical LLC, an American biopharmaceutical company, focuses on developing and commercializing re-purposed drugs to combat Zika and other Flavivirus diseases.

Troy, VT, US🇺🇸

Founded

Atheric Pharmaceutical LLC is an American biopharmaceutical company dedicated to the rapid development and commercialization of re-purposed drugs to prevent and treat Zika and other Flavivirus diseases. Their lead products are reformulated broad-spectrum antiviral drugs that inhibit autophagy-dependent viral replication and other antiviral pathways, aiming to provide broad-spectrum medical countermeasures for neglected tropical diseases.

Atheric Pharmaceutical has made significant strides in addressing public health challenges posed by Flavivirus diseases. By focusing on re-purposed drugs, the company accelerates the availability of effective treatments, contributing to global health security. Their innovative approach has positioned them as a key player in the fight against neglected tropical diseases.

Atheric Pharmaceutical - Similar Companies

Archean Biologics

Veloce BioPharma

Atea Pharmaceuticals

ateapharma.com

Atheric Pharmaceutical - Quick Facts

Who are Atheric Pharmaceutical's competitors?

Companies similar to Atheric Pharmaceutical include Archean Biologics, Veloce BioPharma, Atea Pharmaceuticals and Aether Therapeutics.

When was Atheric Pharmaceutical founded?

Atheric Pharmaceutical was founded in 2013.

Where is Atheric Pharmaceutical's headquarters located?

Atheric Pharmaceutical's headquarters is located in Troy, VT, US.

When was Atheric Pharmaceutical's last funding round?

Atheric Pharmaceutical's most recent funding round was for $100k (USD) in September 2016.

How much disclosed funding has Atheric Pharmaceutical raised?

Atheric Pharmaceutical - Classification

Ownership: Private
Venture-backed
Technology: Biotech
Geographic Exposure: United States

As of Sep 7, 2016, Atheric Pharmaceutical has disclosed funding of $100k (USD). Undisclosed round amounts are excluded.

How many employees does Atheric Pharmaceutical have?

Atheric Pharmaceutical has 7 employees as of Feb 5, 2024.

Revenue: Licensing
Recurring
Software
Customer: Government
Main Product: Drugs
Pharmaceuticals

Tags: Healthtech

NAICS: 540000Professional, Scientific, and Technical Services
541714Research and Development in Biotechnology (except Nanobiotechnology)
541000Professional, Scientific, and Technical Services
541700Scientific Research and Development Services
541710Research and Development in the Physical, Engineering, and Life Sciences
SIC: 8700Engineering, Accounting, Research, Management, And Related Services
8730Research, Development, And Testing Services
8731Commercial Physical and Biological Research

Show 13 more industry codes

NAICS: 320000Manufacturing
325400Pharmaceutical and Medicine Manufacturing
620000Health Care and Social Assistance
325000Chemical Manufacturing
623000Nursing and Residential Care Facilities
325410Pharmaceutical and Medicine Manufacturing
325412Pharmaceutical Preparation Manufacturing
SIC

Aether Therapeutics

Cocrystal Pharma

Arisan Therapeutics

arisanthera.com

Globavir Biosciences

Flugen

flugen.com

Zero Point Five Therapeutics

Aria Pharmaceuticals

Accuitis

accuitis.com

Underdog Pharmaceuticals

cyclaritytx.com

Kathera Bioscience

katherabio.com

Emergo Therapeutics

Aristea Therapeutics

aristeatx.com

2800

Chemicals And Allied Products

8000Health Services

2830Drugs

8040Offices And Clinics Of Other Health Practitioners

2834Pharmaceutical Preparations

8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified